Subject of the day
SPI.L
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
$231.00
▲ +1.00 (+0.4%)
| 52w hi | $248.98 |
|---|---|
| 52w lo | $142.79 |
| Vol | 934.76K |
| As of | Aug 13 |
Our score +0.30
| Short | +0.34 |
|---|---|
| Medium | +0.43 |
| Long | -0.02 |
computed 2026-08-13
Spire Healthcare Group plc
Healthcare · Medical Care Facilities
| Market cap | $925.38M |
|---|---|
| Enterprise value | $2.20B |
| Trailing P/E | 57.75x |
| Forward P/E | 17.12x |
| EV / EBITDA | 10.23x |
| P / S (ttm) | 0.59x |
| Profit margin | 1.0% |
| Return on equity | 2.3% |
| Revenue growth | +4.6% |
| Earnings growth | -19.3% |
| Debt / equity | 176.95 |
| Beta vs SPX | 0.17 |
|---|---|
| Corr SPX | 0.05 |
| Annual vol | 51.8% |
| Annual ret | +6.1% |
| Sharpe | 0.12 |
| Max DD | -46.1% |
Window: 504 trading days (491 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.04 | |
| Sector | +0.12 | |
| Technical | +0.25 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $235.00 | $235.00 | $229.50 | $231.00 | 934.76K |
| Aug 12 | $234.00 | $234.00 | $229.00 | $230.00 | 1.06M |
| Aug 11 | $235.00 | $235.00 | $229.00 | $230.00 | 757.37K |
| Aug 10 | $235.00 | $236.50 | $233.00 | $233.00 | 795.07K |
| Aug 7 | $235.00 | $236.50 | $233.00 | $234.00 | 975.88K |